Pharmaceutical & Biotech
News and Insights
New Computer Bug Compromises Safety of Online Health Info
A new "Heartbleed" computer bug has wreaked havoc on the safety of online health records. This bug has compromised the OpenSSL program which thousands of ...
Eli Lilly to Invest in Drug Tracking System
In an effort to ensure patients are receiving non-counterfeit drugs, Eli Lilly will be investing $110 million into a new tracking system. This system will ...
Pluses and Minuses of using Big Data
In the long run, Big Data will help streamline commercial operations and surprisingly it may be small drugmakers that benefit most with the data. Big ...
Good News for Novartis’ Orphan Drug Jakavi
Novartis' orphan drug, Jakavi, has shown promising results in Phase III clinical trials for the treatment of a rare form of cancer that causes the ...
Actavis to buy Forest Laboratories
In an effort to build up its presence in branded drugs, Actavis has agreed to buy Forest Laboratories. Activas has been busy in the last ...
Merck's consumer unit – Will it stay or will it go?
Kenneth Frazier, Merck's CEO, stated last year that there was a possibility that the company's consumer healthcare would be sold. With the popular brands such ...
New Cost-Control Decisions
With the increasing number of high-priced therapies now on the market, and more in the pipeline, many payers are becoming concerned. The cost for Gilead ...
Novartis Oncology President to become CEO at Incyte
Hervé Hoppenot, president of Novartis Oncology has stepped down to become CEO of Incyte, a longtime partner of Novartis Oncology. Hervé began his career with ...
Auxilium's Xiaflex Receives FDA Approval
The FDA has approved Auxillium's Xiaflex to be used as an injection treatment for Peyronie's disease. This is the first nonsurgical treatment option approved for ...
Gilead Receives FDA Approval
The FDA has approved Savaldi, Gilead's Sciences drug used to treat Hepatitis C. It is expected that doctors will begin using this drug quickly as ...
- page 1 of 2 -